Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2016 - 2025)

Amphastar Pharmaceuticals has reported Goodwill & Intangibles over the past 13 years, most recently at $566.0 million for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $566.0 million for Q4 2025, down 9.96% from a year ago — trailing twelve months through Dec 2025 was $566.0 million (down 9.96% YoY), and the annual figure for FY2025 was $566.0 million, down 9.96%.
  • Goodwill & Intangibles for Q4 2025 was $566.0 million at Amphastar Pharmaceuticals, down from $628.9 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for AMPH hit a ceiling of $635.2 million in Q2 2023 and a floor of $37.0 million in Q3 2022.
  • Median Goodwill & Intangibles over the past 5 years was $575.2 million (2025), compared with a mean of $355.7 million.
  • Biggest five-year swings in Goodwill & Intangibles: decreased 17.79% in 2022 and later surged 1614.89% in 2023.
  • Amphastar Pharmaceuticals' Goodwill & Intangibles stood at $45.0 million in 2021, then decreased by 2.6% to $43.8 million in 2022, then surged by 1329.79% to $626.8 million in 2023, then rose by 0.29% to $628.6 million in 2024, then fell by 9.96% to $566.0 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $566.0 million (Q4 2025), $628.9 million (Q3 2025), and $628.9 million (Q2 2025) per Business Quant data.